Literature DB >> 7827547

Immunisation against chickenpox.

L F Ross, J D Lantos.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7827547      PMCID: PMC2548429          DOI: 10.1136/bmj.310.6971.2

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Attenuated varicella virus vaccine in children with renal transplants.

Authors:  I Zamora; J M Simon; M E Da Silva; A I Piqueras
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

2.  Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.

Authors:  Y Asano; T Nagai; T Miyata; T Yazaki; S Ito; K Yamanishi; M Takahashi
Journal:  Pediatrics       Date:  1985-04       Impact factor: 7.124

3.  Childhood vaccination against chickenpox: an analysis of benefits and costs.

Authors:  D M Huse; H C Meissner; M J Lacey; G Oster
Journal:  J Pediatr       Date:  1994-06       Impact factor: 4.406

4.  Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.

Authors:  B Watson; R Gupta; T Randall; S Starr
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

5.  Cost-effectiveness of a routine varicella vaccination program for US children.

Authors:  T A Lieu; S L Cochi; S B Black; M E Halloran; H R Shinefield; S J Holmes; M Wharton; A E Washington
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

6.  A benefit-cost analysis of a childhood varicella vaccination programme.

Authors:  S R Preblud; W A Orenstein; J P Koplan; K J Bart; A R Hinman
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

  6 in total
  10 in total

1.  Opinions of Quebec parents and vaccinators on the usefulness of chickenpox vaccine.

Authors:  N A Boulianne; B Duval; G D Serres; G Deceuninck; M Dionne; J Carsley; L Valiquette; R Massé
Journal:  Can J Infect Dis       Date:  2001-05

2.  Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group.

Authors:  N J Webb; M M Fitzpatrick; D A Hughes; T J Brocklebank; B A Judd; M A Lewis; R J Postlethwaite; P A Smith; G Corbitt
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

3.  Risk factors for breakthrough varicella in healthy children.

Authors:  Y J Lim; F T Chew; A Y Tan; B W Lee
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

4.  Complications of varicella in a defined central European population.

Authors:  A Jaeggi; R P Zurbruegg; C Aebi
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

5.  Immunisation against chickenpox. Good argument exists for universal vaccination.

Authors:  G R Skinner; J Davies
Journal:  BMJ       Date:  1995-04-01

6.  Chickenpox in the tropics.

Authors:  B W Lee; A Y Tan
Journal:  BMJ       Date:  1995-04-08

Review 7.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

8.  Chickenpox infection after renal transplantation.

Authors:  Anupma Kaul; Raj K Sharma; Dharmendra Bhadhuria; Amit Gupta; Narayan Prasad
Journal:  Clin Kidney J       Date:  2012-04-25

9.  Herd protection effect of N95 respirators in healthcare workers.

Authors:  Xin Chen; Abrar Ahmad Chughtai; Chandini Raina MacIntyre
Journal:  J Int Med Res       Date:  2016-10-26       Impact factor: 1.671

10.  Varicella infections in patients with end stage renal disease: a systematic review.

Authors:  Chong Yau Ong; Sher Guan Low; Farhad Fakhrudin Vasanwala; Shashidhar Baikunje; Lian Leng Low
Journal:  BMC Nephrol       Date:  2018-07-24       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.